Microbiome therapeutics for hepatic encephalopathy is a research paper published in Journal of Hepatology (2021). On theSindex it has a DataRank of 0. It has been cited 94 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AI124255
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23 DK117055
NIAID NIH HHS
Grant: U01 AI124255
National Institutes of Health
Grant: 1U01AI124255-01
Systems biology of Clostridium difficile infection
National Institutes of Health
Grant: 1K23DK117055-01A1
Optimizing Measures for Clinical Trials in Covert Hepatic Encephalopathy
American College of Gastroenterology
American Association for the Study of Liver Diseases
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy
Additional file 1 of Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy
Additional file 2 of Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy
Additional file 2 of Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy
Additional file 3 of Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy
Additional file 3 of Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy
Additional file 1 of Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis
Additional file 1 of Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis